Literature DB >> 18084613

The contribution of transactivation subdomains 1 and 2 to p53-induced gene expression is heterogeneous but not subdomain-specific.

Jennifer M Smith1, Lawton J Stubbert, Jeffrey D Hamill, Bruce C McKay.   

Abstract

Two adjacent regions within the transactivation domain of p53 are sufficient to support sequence-specific transactivation when fused to a heterologous DNA binding domain. It has been hypothesized that these two subdomains of p53 may contribute to the expression of distinct p53-responsive genes. Here we have used oligonucleotide microarrays to identify transcripts induced by variants of p53 with point mutations within subdomains 1, 2, or 1 and 2 (QS1, QS2, and QS1/QS2, respectively). The expression of 254 transcripts was increased in response to wild-type p53 expression but most of these transcripts were poorly induced by these variants of p53. Strikingly, a number of known p53-regulated transcripts including TNFRSF10B, BAX, BTG2, and POLH were increased to wild-type levels by p53(QS1) and p53(QS2) but not p53(QS1/QS2), indicating that either subdomain 1 or 2 is sufficient for p53-dependent expression of a small subset of p53-responsive genes. Unexpectedly, there was no evidence for p53(QS1)- or p53(QS2)-specific gene expression. Taken together, we found heterogeneity in the requirement for transactivation subdomains 1 and 2 of p53 without any subdomain-specific contribution to p53-induced gene expression.

Entities:  

Keywords:  apoptosis; gene expression; microarray; p53; transcription factor

Mesh:

Substances:

Year:  2007        PMID: 18084613      PMCID: PMC2134902          DOI: 10.1593/neo.07688

Source DB:  PubMed          Journal:  Neoplasia        ISSN: 1476-5586            Impact factor:   5.715


  44 in total

Review 1.  A TAD further: exogenous control of gene activation.

Authors:  Anna K Mapp; Aseem Z Ansari
Journal:  ACS Chem Biol       Date:  2007-01-23       Impact factor: 5.100

2.  Transcriptional activation by p53, but not induction of the p21 gene, is essential for oncogene-mediated apoptosis.

Authors:  L D Attardi; S W Lowe; J Brugarolas; T Jacks
Journal:  EMBO J       Date:  1996-07-15       Impact factor: 11.598

3.  p53 transcriptional activation mediated by coactivators TAFII40 and TAFII60.

Authors:  C J Thut; J L Chen; R Klemm; R Tjian
Journal:  Science       Date:  1995-01-06       Impact factor: 47.728

4.  Transactivation ability of p53 transcriptional activation domain is directly related to the binding affinity to TATA-binding protein.

Authors:  J Chang; D H Kim; S W Lee; K Y Choi; Y C Sung
Journal:  J Biol Chem       Date:  1995-10-20       Impact factor: 5.157

5.  Functional domains of wild-type and mutant p53 proteins involved in transcriptional regulation, transdominant inhibition, and transformation suppression.

Authors:  T Unger; J A Mietz; M Scheffner; C L Yee; P M Howley
Journal:  Mol Cell Biol       Date:  1993-09       Impact factor: 4.272

6.  Several hydrophobic amino acids in the p53 amino-terminal domain are required for transcriptional activation, binding to mdm-2 and the adenovirus 5 E1B 55-kD protein.

Authors:  J Lin; J Chen; B Elenbaas; A J Levine
Journal:  Genes Dev       Date:  1994-05-15       Impact factor: 11.361

7.  Induction of apoptosis in HeLa cells by trans-activation-deficient p53.

Authors:  Y Haupt; S Rowan; E Shaulian; K H Vousden; M Oren
Journal:  Genes Dev       Date:  1995-09-01       Impact factor: 11.361

8.  p53 binds to the TATA-binding protein-TATA complex.

Authors:  D W Martin; R M Muñoz; M A Subler; S Deb
Journal:  J Biol Chem       Date:  1993-06-25       Impact factor: 5.157

9.  Functional interactions between p53 and the TFIIH complex are affected by tumour-associated mutations.

Authors:  T Léveillard; L Andera; N Bissonnette; L Schaeffer; L Bracco; J M Egly; B Wasylyk
Journal:  EMBO J       Date:  1996-04-01       Impact factor: 11.598

10.  Four domains of p300 each bind tightly to a sequence spanning both transactivation subdomains of p53.

Authors:  Daniel P Teufel; Stefan M Freund; Mark Bycroft; Alan R Fersht
Journal:  Proc Natl Acad Sci U S A       Date:  2007-04-16       Impact factor: 11.205

View more
  5 in total

1.  The role of mRNA decay in p53-induced gene expression.

Authors:  Brian D Melanson; Reetesh Bose; Jeff D Hamill; Kristen A Marcellus; Elysia F Pan; Bruce C McKay
Journal:  RNA       Date:  2011-10-21       Impact factor: 4.942

2.  A conserved amphipathic helix in the N-terminal regulatory region of the papillomavirus E1 helicase is required for efficient viral DNA replication.

Authors:  Geneviève Morin; Amélie Fradet-Turcotte; Paola Di Lello; Fanny Bergeron-Labrecque; James G Omichinski; Jacques Archambault
Journal:  J Virol       Date:  2011-03-30       Impact factor: 5.103

3.  The War on Cancer rages on.

Authors:  Alnawaz Rehemtulla
Journal:  Neoplasia       Date:  2009-12       Impact factor: 5.715

4.  Neoplasia: the second decade.

Authors:  Alnawaz Rehemtulla
Journal:  Neoplasia       Date:  2008-12       Impact factor: 5.715

5.  NF-κB-dependent role for cold-inducible RNA binding protein in regulating interleukin 1β.

Authors:  Christian Brochu; Miguel A Cabrita; Brian D Melanson; Jeffrey D Hamill; Rosanna Lau; M A Christine Pratt; Bruce C McKay
Journal:  PLoS One       Date:  2013-02-21       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.